NCT01445535 2021-11-03
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
3 trialsNCT00113646 2018-03-16
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
Massachusetts General Hospital
Phase 2 Terminated
NCT00105313 2007-06-14
Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia
MedImmune LLC
Phase 1 Terminated